Lv4
406 积分 2021-11-15 加入
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
1小时前
待确认
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
2小时前
已完结
Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer
4天前
已完结
Cetuximab for treating non-small cell lung cancer
4天前
已完结
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications
11天前
已完结
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
13天前
已完结
PD‐L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy
16天前
已完结
193 PD-L1 expression in gastroesophageal cancer: A systematic literature review
16天前
已关闭
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
16天前
已完结
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
16天前
已完结
皖公网安备34019202002308
